Showing results (811-820 of 1,000) with videos related to
Sort By:
Pageof 100
Assay and Drug Development Technologies|June 17, 2011
A flow cytometry-based assay for screening FimH antagonistsMeike Scharenberg, Daniela Abgottspon, Evelin Cicek, et al.Assay and Drug Development Technologies|December 16, 2014
A zebrafish in vivo phenotypic assay to identify 3-aminothiophene-2-carboxylic acid-based angiogenesis inhibitorsAthanasios Papakyriakou, Panagiotis Kefalos, Panagiotis Sarantis, et al.Assay and Drug Development Technologies|September 19, 2015
Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor ScreeningSarah J Duellman, Wenhui Zhou, Poncho Meisenheimer, et al.Assay and Drug Development Technologies|August 5, 2015
Computational and Practical Aspects of Drug RepositioningTudor I Oprea, John P OveringtonAssay and Drug Development Technologies|December 20, 2015
The 13th Annual Aurora Biomed Ion Channel Retreat: Three Days of Research, Technology, and NetworkingKaylee E A Magee, Shawna R StanwoodAssay and Drug Development Technologies|December 23, 2015
A Critical Review of Repurposing Apomorphine for Smoking CessationJoel A Morales-Rosado, Margot A Cousin, Jon O Ebbert, et al.Assay and Drug Development Technologies|December 23, 2015
Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case StudyAndrew J Krouse, Lloyd Gray, Timothy Macdonald, et al.Assay and Drug Development Technologies|April 6, 2016
Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish ModelsXiao-Yu Zhu, Bo Xia, Hong-Cui Liu, et al.Assay and Drug Development Technologies|April 6, 2016
Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant EnterobacteriaceaeKenneth P Smith, James E KirbyAssay and Drug Development Technologies|March 19, 2016
Pharmacological Modulation of GluK1 and GluK2 by NETO1, NETO2, and PSD95Baolin Li, Elizabeth Rex, He Wang, et al.Pageof 100